Sort
17,288 grants matching “multiple sclerosis”
Neuropeptides and Regulatory T Cells
$348,975Doina Ganea · Temple Univ Of The Commonwealth · R01 · FY2013 · AI
Mitigation of nuclear pore dysfunction in c9FTD/ALS pathogenesis
$348,955Jeffrey D Rothstein · Scripps Florida · P01 · FY2019 · NS
Mitigation of nuclear pore dysfunction in c9FTD/ALS pathogenesis
$348,955Jeffrey D Rothstein · Scripps Florida · P01 · FY2018 · NS
SNARE complex-mediated exocytosis in oligodendrocyte differentiation and survival
$348,943Akiko Nishiyama · University Of Connecticut Storrs · R01 · FY2021 · NS
SNARE complex-mediated exocytosis in oligodendrocyte differentiation and survival
$348,943Akiko Nishiyama · University Of Connecticut Storrs · R01 · FY2022 · NS
SNARE complex-mediated exocytosis in oligodendrocyte differentiation and survival
$348,943Akiko Nishiyama · University Of Connecticut Storrs · R01 · FY2023 · NS
SNARE complex-mediated exocytosis in oligodendrocyte differentiation and survival
$348,943Akiko Nishiyama · University Of Connecticut Storrs · R01 · FY2020 · NS
Does chronic Theiler's demyelination require viral persistence?
$348,906Howard Lee Lipton · University Of Illinois At Chicago · R01 · FY2015 · NS
Muscarinic Receptor Type 3 Regulation of Oligodendrocyte Progenitor Differentiation
$348,906Fraser James Sim · State University Of New York At Buffalo · R01 · FY2018 · NS
Muscarinic Receptor Type 3 Regulation of Oligodendrocyte Progenitor Differentiation
$348,906Fraser James Sim · State University Of New York At Buffalo · R01 · FY2020 · NS
Muscarinic Receptor Type 3 Regulation of Oligodendrocyte Progenitor Differentiation
$348,906Fraser James Sim · State University Of New York At Buffalo · R01 · FY2019 · NS
Muscarinic Receptor Type 3 Regulation of Oligodendrocyte Progenitor Differentiation
$348,906Fraser James Sim · State University Of New York At Buffalo · R01 · FY2021 · NS
Muscarinic Receptor Type 3 Regulation of Oligodendrocyte Progenitor Differentiation
$348,906Fraser James Sim · State University Of New York At Buffalo · R01 · FY2022 · NS
Structure-Function Studies of Chemokines and Receptors
$348,901Tracy M Handel · University Of California, San Diego · R01 · FY2007 · AI
Characterization of uveitogenic T cells
$348,900University Of Louisville · R01 · FY2003 · EY
Mechanisms of fibrin action in multiple sclerosis
$348,886Katerina Akassoglou · University Of California, San Diego · R01 · FY2006 · NS
T cell response to myelin proteolipid protein
$348,842Vijay K Kuchroo · Brigham And Women'S Hospital · R01 · FY2014 · NS
TREATMENT OF AUTOIMMUNITY WITH RECEPTOR-MODIFIED T CELLS
$348,812Terrence L Geiger · St. Jude Children'S Research Hospital · R01 · FY2008 · AI
Manual Control of the Upper Esophageal Sphincter
$348,744Peter Belafsky · University Of California At Davis · R01 · FY2011 · DK
B7/CD28/CTLA-4 COSTIMULATION IN PATHOGENESIS OF R-EAE
$348,700Northwestern University · R01 · FY2003 · NS
Optimizing mesenchymal stem cell and Treg immunosuppression for controlling SLE
$348,700Melvin Edward Medof · Case Western Reserve University · R01 · FY2017 · AR
Optimizing mesenchymal stem cell and Treg immunosuppression for controlling SLE
$348,700Melvin Edward Medof · Case Western Reserve University · R01 · FY2016 · AR
Optimizing mesenchymal stem cell and Treg immunosuppression for controlling SLE
$348,700Melvin Edward Medof · Case Western Reserve University · R01 · FY2015 · AR
B7/CD28/CTLA-4 COSTIMULATION IN PATHOGENESIS OF R-EAE
$348,700Northwestern University · R01 · FY2000 · NS
B7/CD28/CTLA-4 COSTIMULATION IN PATHOGENESIS OF R-EAE
$348,700Northwestern University · R01 · FY2002 · NS